What You Should Know:
Shimmer, an innovative online coaching platform designed for adults with ADHD today announces it has raised $2.2 million in seed funding.The round was co-led by Worklife Ventures and SeedtoB Capital, with participation from Koa Labs, Aglaé…
Continue Reading
Background: Interventions targeting the nutritional quality of grocery shopping have the potential to help improve diet and health outcomes. Objective: This study aims to assess the feasibility and acceptability of receiving advice on healthier…
Continue Reading
Eisai’s collaboration with Oita University heralds a milestone in Alzheimer’s research, presenting an innovative AI model utilizing wearable device data for prediction. The study’s comprehensive approach, encompassing both biological and lifestyle data, results in…
Continue Reading
Digital phenotyping refers to characterizing human bio-behavior through wearables, personal devices, and digital health technologies. Digital phenotyping in populations facing a disproportionate burden of type 2 diabetes (T2D) and health disparities continues to lag…
Continue Reading
Background: Low-intensity cognitive behavioral therapy (LICBT) has been implemented by the Improving Access to Psychological Therapies services across England to manage excessive worry associated with generalized anxiety disorder and support emotional well-being. However, barriers…
Continue Reading
Background: Physical inactivity and a poor diet are modifiable behaviors that contribute to obesity. Obesity is a well-recognized risk factor for chronic diseases, including diabetes. Mobile health (mHealth) apps can play an important adjuvant…
Continue Reading
By Shania Kennedy
January 10, 2024 – Researchers have developed a risk score to predict intensive care unit (ICU) admission and ICU survival among community-dwelling older adults, according to a study published in Health Science Reports.
The…
Japanese pharmaceutical company Eisai, together with Oita University in Japan, has built what could be the world’s first AI model that uses data from wearable devices to predict Alzheimer’s disease, the most common form…
Continue Reading
Jim DiCesare, Sr. Director, Study Operations, IQVIA Clinical Trial Payments
Escalating competition for clinical trial sites, in tandem with other industry-wide challenges such as changing regulations; a lack of bandwidth and resources; identifying ideal sites…
Continue Reading
By Shania Kennedy
January 09, 2024 – A research team from the Icahn School of Medicine at Mount Sinai has developed an artificial intelligence (AI) tool to help predict which cardiovascular patients are at increased risk…
Continue Reading
